Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Holdhoff M, Nicholas MK, Peterson RA, Maraka S, Liu LC, Fischer JH, Wefel JS, Fan TM, Vannorsdall T, Russell M, Iacoboni M, Tarasow TM, Hergenrother PJ, Dudek AZ, Danciu OC. Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. Neurooncol Adv 2023;5:vdad087. [PMID: 37554223 PMCID: PMC10406430 DOI: 10.1093/noajnl/vdad087] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/10/2023] Open

For:	Holdhoff M, Nicholas MK, Peterson RA, Maraka S, Liu LC, Fischer JH, Wefel JS, Fan TM, Vannorsdall T, Russell M, Iacoboni M, Tarasow TM, Hergenrother PJ, Dudek AZ, Danciu OC. Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. Neurooncol Adv 2023;5:vdad087. [PMID: 37554223 PMCID: PMC10406430 DOI: 10.1093/noajnl/vdad087] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/10/2023] Open

Number

Cited by Other Article(s)

Huang M, Li S, Li P, Kang Z, Zhang B, Li W. Drug clinical trials on high-grade gliomas: challenges and hopes. Cancer Biol Med 2024;20:j.issn.2095-3941.2023.0364. [PMID: 38318805 PMCID: PMC10845939 DOI: 10.20892/j.issn.2095-3941.2023.0364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Accepted: 11/24/2023] [Indexed: 02/07/2024] Open